Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.
about
Infections and Brain DevelopmentCytomegalovirus in pregnancy: to screen or not to screen.Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and preventionImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelCytomegalovirus infection in pregnancyImportance of diagnostic work-up of Guillain-Barré syndrome in pregnancy.Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatmentPreexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placentaAwareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study.Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection.The "silent" global burden of congenital cytomegalovirus.Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.Cytomegalovirus in the neonate: immune correlates of infection and protectionCongenital cytomegalovirus infection: new prospects for prevention and therapyPentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope proteinPrimary Human Cytomegalovirus (HCMV) Infection in Pregnancy.Intrauterine growth restriction caused by underlying congenital cytomegalovirus infectionTwin pregnancy and congenital cytomegalovirus: case report and review.Diagnosis and prognosis of congenital CMV infection: a case report and review of the literature.Perinatal outcome after maternal primary cytomegalovirus infection in the first trimester: a practical update and counseling aid.Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.Optimum treatment of congenital cytomegalovirus infection.Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.Maternal immune correlates of protection against placental transmission of cytomegalovirus.Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.Preventing Congenital Cytomegalovirus Infection.High Cytomegalovirus (CMV) DNAemia Predicts CMV Sequelae in Asymptomatic Congenitally Infected Newborns Born to Women With Primary Infection During Pregnancy.Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging.Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirusHyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention.
P2860
Q26778598-250A0414-CF47-4DEB-9C89-EFAE0B3B7C26Q26851794-3E8CC306-1F42-4121-B9A3-31927465915FQ27024030-95A4506B-E096-4100-AE80-F3450EC8CB34Q27026924-22F12A23-2F2B-4E50-8E0D-8BBDB5F86576Q29994481-6498E69E-2986-4766-8A66-BD9FEDBAA1C2Q33437291-8896A1EE-5D25-44A0-809E-E33A50A192CCQ33568646-683474E0-B2FF-4F9D-B1DE-A099FDC38312Q33877783-97795061-BFED-49E3-BEAA-E1DB899C6B5BQ35488673-6CDEE2DD-FD9C-412D-BD54-701941EC4244Q36403590-7A32F6EF-AD9D-4F10-80A2-B046281ACA95Q36505218-6015755A-7017-4F61-9186-1E70994A89B4Q36558293-74534997-D006-4C12-A50A-4D782E0828FCQ36834814-F5072066-B64D-4171-B989-F9116BDD61D4Q37140130-55B65FBA-E464-4F43-A978-FD6879168275Q37254183-44C63EE3-1C09-4CE7-B793-77D2A55281BCQ37409489-9FF6CFC8-721B-4CEA-9F8A-778A63C15528Q37519151-ACA7273B-7A33-4F24-9F45-A5CBC359CCF8Q37656015-CA1AF952-DB7E-4ED7-A5E9-359595ED8D2FQ37719762-20B594E2-9C9B-4DF1-B664-F26FCF3CD1AAQ38058345-729B0E91-0A5B-4F7B-A2F7-B9941E20352AQ38235995-FCE1C82C-DEE8-4D79-9645-7B29DC31BF38Q38249909-04F3072F-35C8-4259-807B-4421A46C4418Q38260298-AA2390C1-79D2-4FB9-838C-AA59F08C289CQ38590590-21191D9D-F96F-4215-9B8C-DEAD130F1DA1Q38708710-7C04C424-E9C6-42F7-A3E0-EC72CAF76ADBQ38797872-15516D12-4623-48F0-ACDB-D84A66829777Q39051240-FA3386DB-D569-43D8-A009-00EB12F1ECFBQ39272221-7142C3E8-861B-41D3-B996-48D5BD3F0E28Q40059344-B0FCA604-9AF3-4BD9-8BE5-E79E92D02166Q40086042-286A94AB-C1C0-4D21-B20E-F47C78645B66Q41667491-9EDD3A90-16B9-4D27-829E-7B91D1B430BCQ41991189-CBF48595-A693-457D-82CF-0EC5394DCB5CQ42222597-8CE14A11-CD01-467D-941A-4DC0EEF82435Q42280136-6BB6EA3F-82D8-4F78-B07C-81A24CEF6D11Q42572343-52CD3685-4344-411D-84C1-1EBA1A99F64FQ50087895-B0A3A1A2-E4EF-40AE-8150-C689C0BE9AAAQ54956176-FCA970DF-D196-4864-8B22-6EE48117BB1A
P2860
Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@ast
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@en
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@nl
type
label
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@ast
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@en
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@nl
prefLabel
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@ast
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@en
Early primary cytomegalovirus ...... mong infants at 1 year of age.
@nl
P2093
P356
P1476
Early primary cytomegalovirus ...... among infants at 1 year of age
@en
P2093
Anna Da Roit
Carla Morando
Eleonora Salviato
Erich Cosmi
Fioretta Marciani Magno
Gabriella Forner
Giorgio Palu
Laura Milanese
Mario Ermani
P304
P356
10.1093/CID/CIS423
P407
P577
2012-04-26T00:00:00Z